Suzanne Lussier-Cacan, Aline Bolduc, Marianne Xhignesse, Théophile Niyonsenga, Charles F. Sing

Size: px
Start display at page:

Download "Suzanne Lussier-Cacan, Aline Bolduc, Marianne Xhignesse, Théophile Niyonsenga, Charles F. Sing"

Transcription

1 Impact of Alcohol Intake on Measures of Lipid Metabolism Depends on Context Defined by Gender, Body Mass Index, Cigarette Smoking, and Apolipoprotein E Genotype Suzanne Lussier-Cacan, Aline Bolduc, Marianne Xhignesse, Théophile Niyonsenga, Charles F. Sing Abstract Hyperlipidemia, smoking, and obesity are well-known risk factors for cardiovascular disease. Conversely, moderate alcohol intake is associated with lower atherosclerosis risk. However, the influence of taking alcohol on the interrelationships of these factors in a particular context has not been thoroughly investigated. In this study, we asked whether the association between plasma measures of lipid metabolism and alcohol intake is dependent on context defined by gender, age, body mass index (BMI), smoking, and apolipoprotein E (APOE) genotype. Data were obtained in a sample of 869 women and 824 men who participated in the Quebec Heart Health Survey. There was no evidence that variation among APOE genotypes influenced the association between LDL cholesterol (LDL-C) or HDL cholesterol (HDL)-C and alcohol, after adjustment for age and BMI. Further, the positive (LDL-C and BMI) and the negative (HDL-C and BMI) associations that were observed in men and women with the 3/2 and 3/3 genotypes were not modified by alcohol intake. However, in women with the 4/3 genotype only, we found a significant influence of an alcohol by BMI interaction on the prediction of total cholesterol, LDL-C, HDL-C, apoa-i, and apob, and this interaction was influenced by the status of smoking. Whereas the influence of an alcohol by BMI interaction on total cholesterol and LDL-C was significant in smokers, its influence on HDL-C was significant only in non-smokers. This study emphasizes the context dependency of the influence of alcohol on lipid metabolism and demonstrates how biological, environmental, and genetic factors interact to determine cardiovascular disease risk. (Arterioscler Thromb Vasc Biol. 2002;22: ) Key Words: risk factors lipoproteins gender apolipoprotein E polymorphism context dependency Hyperlipidemia is a major risk factor for cardiovascular disease (CVD). 1,2 Plasma lipid, lipoprotein, and apolipoprotein levels are influenced by biological indices (ie, age and weight), environmental (diet, alcohol, smoking, and physical activity), and genetic variations. Although the separate influence of each of these measures of individuality on the prediction of plasma levels of lipid traits has been broadly studied, their combined effects are less understood. Several studies have evaluated the influence of alcohol intake, an index of lifestyle, on plasma lipid and lipoprotein concentrations (reviewed by Savolainen and Kesäniemi 3 ). A moderate intake of alcohol is associated with protection against coronary heart disease, probably due in part to a dose-dependent increase in HDL cholesterol (HDL-C). 4 A decrease in LDL cholesterol (LDL-C) with increased alcohol intake has also been reported in some studies, but this effect is less consistent and probably depends on the combination of one or more unmeasured factors. 3 Until recently, most crosssectional studies of the influence of alcohol have been performed in men or in pooled samples of women and men. Furthermore, most studies have been conducted without control for potential genetic or environmental factors. In studies of the effects of alcohol on lipoprotein metabolism, smoking has been identified as a key interacting factor. 5,6 Cigarette smoking generally increases total cholesterol (TC) and triglyceride (TG), VLDL cholesterol (VLDL-C) and LDL-C levels and decreases HDL-C and apolipoprotein (apo) A-I levels. 7 Thus, alcohol intake and cigarette smoking exert opposite effects on LDL and HDL metabolism. A few studies, conducted mostly in men, have evaluated the interaction of these habits on blood lipids. Generally, it is expected that the effects of one could be modified by the influence of the other. 8,9 The influence of variation in the gene coding for apoe on interindividual variation in the regulation of lipid metabolism has been abundantly studied. 10 Individuals who carry the 4 allele generally have the highest and those with the 2 allele the lowest levels of LDL-C. The few studies that have evaluated the impact of the interaction between measures of lifestyle and the apoe polymorphism on lipid traits have Received January 23, 2002; revision accepted February 22, From the Hyperlipidemia and Atherosclerosis Research Group (S.L.-C., A.B., M.X.), Clinical Research Institute of Montreal, Montreal, Quebec, Canada; Département de médecine familiale (M.X.), Faculté de médecine, Université de Sherbrooke and Centre de recherche clinique (M.X., T.N.), Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada; Department of Human Genetics (C.F.S.), University of Michigan, Ann Arbor, Mich. Correspondence to Dr Suzanne Lussier-Cacan, 110 Pine Ave West, Montreal, Quebec, H2W 1R7. cacans@ircm.qc.ca 2002 American Heart Association, Inc. Arterioscler Thromb Vasc Biol. is available at DOI: /01.ATV C 824

2 Lussier-Cacan et al Context Dependency of Alcohol Effect on Lipoproteins 825 provided inconsistent results. Work from our group has shown that the influence of an interaction between age and anthropometric status on interindividual variation in blood lipid levels is dependent on APOE genotype The aim of the present study was to extend these studies to determine the degree to which the association between plasma lipids, lipoproteins and apolipoproteins and alcohol intake is dependent on the context of the individual defined by gender, age, body mass index (BMI), smoking status, and APOE genotype. Methods Sample Details of the sampling design have been previously published. 17 Briefly, subjects were women and men aged 18 to 74 years participating in two complementary studies in the Province of Quebec (Canada), the Heart Health Survey and the Nutrition Survey, during the fall of During an auxiliary study of plasma apolipoproteins, apoa-i and apob levels were determined, and apoe phenotyping was performed. Finally, data from the 3 studies were combined into a sample of 2010 subjects (1025 women and 985 men). Subjects with missing lipid measures or lifestyle data, as well as those presenting with the less common apoe phenotypes E2/2, E4/2, and E4/4 ( 5%) were excluded from the study, leaving a sample of 869 women and 824 men. Data Collection Anthropometric data (height and weight, waist and hip circumferences) and information on lifestyle habits were obtained during the clinic visit and the interview as part of the Heart Health Survey. BMI was calculated as weight in kilograms divided by height in meters squared. Plasma TC, total TG, HDL-C, apoa-i, and apob concentrations were determined from the fasting blood sample. All of these assays were carried out under standardized conditions at the Lipid Research Laboratory of the University of Toronto, as previously described. 18,19 LDL-C was calculated by using the equation of Friedewald et al, 20 and VLDL-C was derived by subtracting LDL-C and HDL-C from TC. Thus, subjects with triglyceride levels 5.0 mmol/l were excluded in our study. ApoE phenotyping was performed at the Clinical Research Institute of Montreal, according to the method described by Hill and Pritchard. 21 Six APOE genotypes, 2/2, 3/2, 3/3, 4/3, 4/2, and 4/4, defined by the three polymorphic alleles, 2, 3, and 4, were inferred from the isoform phenotypes E2/2, E3/2, E3/3, E4/3, E4/2, and E4/4. In the Heart Health Survey, subjects were asked to provide information on their daily alcohol intake (number of drinks) during the 7 days preceding their clinic visit. In our sample, as a large proportion of subjects were non-drinkers (44% of women and 30% of men), we chose to study the influence of alcohol intake on lipid traits by dividing subjects into 2 categories: non-drinkers (number of drinks/d 0) and drinkers (number of drinks/d 0). Information on cigarette smoking habits was also collected during the clinic visit. Subjects were asked to report the number of cigarettes usually smoked in a day. Occasional cigarette smokers and pipe or cigar smokers were considered non-smokers. Because a large number of subjects were non-smokers (70% of women and 73% of men), we also chose to evaluate the influence of smoking as a discrete variable: non-smokers (number of cigarettes/d 0) and smokers (number of cigarettes/d 0). Statistical Analyses All analyses were performed separately for women and men by using the SAS software (SAS Institute Inc, 1993, Version 6). To reduce positive skewness, the log (base 10) transformation of triglyceride and VLDL-C values was used in all analyses. The means of all variables were first calculated on the raw data, for each of the 3 most common APOE genotype subgroups ( 3/2, 3/3, and 4/3). By using the t test, statistical significance of the difference between nondrinkers and drinkers was evaluated separately for each APOE genotype. The F statistic was used to test the hypothesis of equality of subgroup variances. Satterthwaite s approximation of the t test was applied when subgroup variances were significantly different. 22 The 2 contingency test was used to assess differences in the relative frequencies of smokers between non-drinkers and drinkers. Separate regression equations were estimated for women and men, as the distributions of lipid traits and relationships with most other traits are known to be gender specific. 14,17,23,24 Four regression models (denoted heretoforth as models A D) were used to evaluate the contribution of each variable (age, BMI, alcohol) and interactions to lipid trait variability in each APOE genotype subgroup separately. First, model A evaluated the contribution of age (to the third order) and BMI to lipid trait variability. In model B A, the additional contribution of alcohol intake (as a discrete variable) to lipid trait variation was evaluated, after adjustment for age and BMI. Next, in model C AB, the additional contribution to lipid trait variation of the interaction between age and alcohol intake was estimated, after adjustment for age, BMI, and alcohol intake. In model D ABC, the additional contribution to lipid trait variation of the interaction between BMI and alcohol intake was considered, after adjustment for age, BMI, alcohol intake, and the interaction of age with alcohol intake. Model D, the complete model, was also applied separately in non-smokers and smokers, to evaluate the combined effects of drinking and smoking habits on lipid traits. Finally, to determine whether results of the regression analyses were significantly different among APOE genotype groups, a test of homogeneity was performed for each regression model by using the F ratio. 25 The F ratio statistic, as defined by F [SSR (complete model, including interaction terms between variables and APOE) SSR (reduced model, excluding interaction terms with APOE)/degrees of freedom associated with the difference]/mse (complete model), where SSR and MSE are sums of squares due to regression and mean square error, respectively, is simply a test of the interaction between APOE genotypes and variables in the regression model considered. Whenever statistically significant heterogeneity was detected, pairwise comparisons of the 3/2 orthe 4/3 genotype with the most common genotype 3/3 were carried out. In this study, the 0.05 level of probability was considered the criterion for significance of a test statistic. Results For the characteristics of women and men according to APOE genotype and drinking status, please see Table I (available at Subjects consuming alcohol were generally younger and female drinkers had a lower BMI than non-drinkers. The number of daily drinks consumed was comparable in the 3 APOE genotype subgroups in both women and men. However, the percentage of smokers among drinkers, compared with the percentage among non-drinkers, was significantly greater in women with the 4/3 genotype. The lipid traits, TC, LDL-C, apob, VLDL-C, and TG were significantly lower in female drinkers than in non-drinkers in the 3/3 and 4/3 subgroups, but there were no differences in men. In the 3 APOE genotype subgroups, HDL-C and apoa-i levels were significantly higher in women who consumed alcohol than in those who abstained, whereas HDL-C in men was significantly increased in drinkers compared with non-drinkers only in those with the 3/3 genotype, while apoa-i levels were significantly higher in drinkers in all 3 APOE genotype subgroups. The influence of age, BMI, and alcohol intake was estimated by using multiple regression models in women (Table 1) and men (Table 2). These tables show the percentage of sample variability in lipid traits associated with each regression model (R 2 100) and the corresponding level of signif-

3 826 Arterioscler Thromb Vasc Biol. May 2002 TABLE 1. Influence (R 2 100) of Age, BMI, Alcohol Intake (Non-drinkers, Drinkers) on Lipid, Lipoprotein, and Apolipoprotein Levels in Women 3/2 (n 129) 3/3 (n 561) 4/3 (n 179) A B A C AB D ABC Total A B A C AB D ABC Total A B A C AB D ABC Total TC R 2 ( 100) Prob NS NS NS NS NS NS NS NS * Log R 2 ( 100) VLDL-C Prob NS NS NS NS NS * NS NS NS LDL-C R 2 ( 100) Prob NS NS NS * NS NS NS NS HDL-C R 2 ( 100) Prob * * NS NS * NS NS * NS Log TG R 2 ( 100) Prob NS NS NS NS NS * NS NS NS ApoA-I R 2 ( 100) Prob * NS NS NS NS NS ApoB R 2 ( 100) Prob NS NS NS * NS NS NS NS Model A age, age 2, age 3, BMI; model B A (R for model A alcohol) (R for model A only); Model C AB (R for models A B age alcohol, age 2 alcohol, age 3 alcohol) (R for models A B only); Model D ABC (R for models A B C BMI alcohol) (R for models A B C only). NS indicates not significant at the P 0.10 level of probability. Significance (Prob) of the regression models: *P 0.05, P 0.01, P icance (P value) in each of the 3 APOE genotypes. In women and men, age and BMI (model A) made the largest contribution to trait variability. The R values for model A varied from 6% (apoa-i) to 42% (TC) in women (Table 1) and from 2% (apoa-i) to 28% (TC) in men (Table 2). This influence of age and BMI was significantly heterogeneous among APOE genotype subgroups in men for TC, LDL-C, and apob ( 3/2 versus 3/3, Table 3), but not in women. In model B A, the influence of alcohol intake on lipid traits was determined after adjustment for age and BMI. In women (Table 1), alcohol consumption contributed significantly to the variability in HDL-C (R % to 4%) and apoa-i TABLE 2. (R % to 11%) in each of the 3 APOE genotype subgroups. The influence of alcohol consumption on the variability of apoa-i was significantly greater in women with the 3/2 genotype (R %) compared with 3/3 (R %) (test of homogeneity, Table 3). In men (Table 2), the contribution of alcohol intake to HDL-C variability was significant in the 3/3 subgroup only (R %), whereas the impact on apoa-i was significant in all 3 APOE genotypes (R was 4% in each). There was no significant heterogeneity for these effects among the APOE genotypes in men (Table 3). Except for LDL-C and apob in women with the 3/3 genotype, the influence of alcohol Influence (R 2 100) of Age, BMI, Alcohol Intake (Non-drinkers, Drinkers) on Lipid, Lipoprotein, and Apolipoprotein Levels in Men 3/2 (n 121) 3/3 (n 541) 4/3 (n 162) A B A C AB D ABC Total A B A C AB D ABC Total A B A C AB D ABC Total TC R 2 ( 100) Prob NS NS NS NS NS NS NS NS NS Log R 2 ( 100) VLDL-C Prob NS NS NS NS NS NS NS NS NS LDL-C R 2 ( 100) Prob * NS NS NS * NS NS NS NS NS NS HDL-C R 2 ( 100) Prob NS NS NS NS NS NS NS NS NS NS Log TG R 2 ( 100) Prob NS NS NS NS NS NS NS NS NS ApoA-I R 2 ( 100) Prob NS * NS NS NS NS NS NS NS * ApoB R 2 ( 100) Prob NS NS NS NS NS NS NS NS * Legend in Table 1.

4 Lussier-Cacan et al Context Dependency of Alcohol Effect on Lipoproteins 827 TABLE 3. Significance of the Tests of Homogeneity Among APOE Genotypes of the Influence on Lipid Traits of Age and BMI (A), Alcohol Intake (B A) and of the Interaction Between Alcohol and Age (C AB) or Alcohol and BMI (D ABC) D ABC A B A C AB D ABC Non-smokers Smokers Women n 608 n 261 TC NS NS NS ( 4/3 vs 3/3)* NS ( 4/3 vs 3/3)* Log VLDL-C NS NS NS NS NS NS LDL-C NS NS NS ( 4/3 vs 3/3) NS ( 4/3 vs 3/3)* HDL-C NS NS NS ( 4/3 vs 3/3)* ( 4/3 vs 3/3)* NS Log TG NS NS NS NS NS NS ApoA-I NS ( 3/2 vs 3/3)* NS NS NS NS ApoB NS NS NS ( 4/3 vs 3/3) ( 4/3 vs 3/3)* NS Men n 599 n 225 TC ( 3/2 vs 3/3) NS NS NS Log VLDL-C NS NS NS NS LDL-C ( 3/2 vs 3/3)* NS NS NS HDL-C NS NS NS NS Log TG NS NS NS NS ApoA-I NS NS NS NS ApoB ( 3/2 vs 3/3)* NS NS NS Complete model A APOE, age, age 2, age 3, BMI, age APOE, age 2 APOE, age 3 APOE, BMI APOE; complete model B A APOE, age, age 2, age 3, BMI, alcohol, age APOE, age 2 APOE, age 3 APOE, BMI APOE, alcohol APOE; complete model C AB APOE, age, age 2, age 3, BMI, alcohol, age alcohol, age 2 alcohol, age 3 alcohol, age APOE, age 2 APOE, age 3 APOE, BMI APOE, alcohol APOE, age alcohol APOE, age 2 alcohol APOE, age 3 alcohol APOE; complete model D ABC APOE, age, age 2, age 3, BMI, alcohol, age alcohol, age 2 alcohol, age 3 alcohol, BMI alcohol, age APOE, age 2 APOE, age 3 APOE, BMI APOE, alcohol APOE, age alcohol APOE, age 2 alcohol APOE, age 3 alcohol APOE, BMI alcohol APOE in all subjects and according to smoking status. Significance of the test of homogeneity for each regression model and significance of contrasts between genotypes 3/2 and 3/3 or 3/3 and 4/3 on uncensored sample for outliers: *P 0.05, P 0.01, P intake was not significant on any of the other traits. In both cases, the contribution was less than 1%. Our analysis strategy also included testing for the contribution of interactions between alcohol intake and age or BMI to variation in lipid traits within each genotype subgroup. There were no significant statistical interactions between age and alcohol (model C AB), in women (Table 1) or men (Table 2). However, the influence of a statistically significant interaction between alcohol and BMI (model D ABC) was observed for TC, LDL-C, HDL-C, apoa-i and apob in women with the 4/3 genotype, for log VLDL-C and log TG in the 3/3 women subgroup (Table 1), and for apoa-i and apob in men with the 3/3 and the 4/3 genotypes, respectively (Table 2). The tests of homogeneity revealed significant differences in women between the 4/3 and the 3/3 genotypes in the influence of the alcohol by BMI interaction on interindividual variation in TC, LDL-C, HDL-C, and apob. None of these tests were statistically significant in men (Model D ABC, Table 3). Figure 1 illustrates the heterogeneity among APOE genotypes, in women, of the influence of the interaction between alcohol and BMI on LDL-C. No significant interaction was observed for women with the 3/2 and 3/3 genotypes, but in women with the 4/3 genotype, increasing LDL-C concentrations were strongly associated with increasing BMI in drinkers but not in non-drinkers. To minimize the possible influence of outliers on this relationship, values of any of the traits exceeding 4 SDs above and below the mean were removed and the analyses of women repeated. Thirteen subjects were removed because of outlying values for one or more of the traits. The censored and balanced sample included 856 instead of 869 women. For TC, LDL-C, and apob, exclusion of these women lowered the observed level of significance (P value) of the differences, but those statistically significant differences observed in the larger data set for LDL-C, HDL-C, and apob were retained, and apoa-i became significant at the 0.05 level of probability. Henceforth, while uncensored data are shown in Table 3, censored data are used in Figures 2 and 3. Next, we asked whether smoking had an impact on the influence of the interaction between alcohol intake and BMI on lipid traits. The contribution of the interaction between alcohol and BMI to the variability of TC and LDL-C in women was found to be significantly different among genotype subgroups in smokers only (Table 3). Figure 2 shows that in 4/3 women who smoked, higher LDL-C levels were not associated with higher BMI values in the absence of alcohol, in contrast to the strong positive relationship observed in female smokers who consumed alcohol. However, although similar trends were observed in women who did not smoke, taking or not taking alcohol did not significantly influence the statistical relationship between LDL-C and

5 828 Arterioscler Thromb Vasc Biol. May 2002 Figure 1. Regression lines showing the association between BMI and predicted LDL-C levels (mmol/l) in women as a function of drinking status (non-drinkers and drinkers) in each APOE genotype subgroup. The P value presented in the figure is the probability associated with the regression coefficient ( ) obtained in model D for the interaction term BMI alcohol on the total sample (model defined in Table 1). BMI. Furthermore, the heterogeneity in the association between apob and BMI observed between the 4/3 and the 3/3 genotypes for female non-smokers in the total sample (Table 3) was no longer significant in the censored sample (not shown). For HDL-C, the contribution of the interaction between alcohol and BMI to trait variability was found to be statistically different among APOE genotypes only in nonsmokers (Table 3). Specifically, as illustrated in Figure 3, a significant decrease in HDL-C levels was associated with increasing BMI only in 4/3 female non-smokers who consumed alcohol, in contrast to the negative association between HDL-C and BMI observed in women who smoked, consuming alcohol or not. Similar results were observed in the analysis of apoa-i (not shown). Discussion We previously reported that the relationships between lipid traits and age, BMI, or waist-to-hip ratio are influenced by APOE genotype. 17 In the current study of the same sample, our objective was to evaluate the extent to which the associations between lipid traits and alcohol intake are influenced by the apoe polymorphism, while taking into account other measures of context, ie, gender, age, body size, and cigarette smoking. Although this statistical work does not provide any information about the molecular and physiological mechanisms involved in determining the complex biological relationships among these traits, it provides valuable insight into how these established risk factors might be best used to improve the accuracy of predicting an individual s Figure 2. Regression lines showing the association between BMI and predicted LDL-C levels (mmol/l) according to drinking status (non-drinkers and drinkers) in women with the 3/3 and 4/3 genotypes, in smokers (upper panel) and nonsmokers (lower panel). The P value presented in the figure is the probability associated with the regression coefficient ( ) obtained in model D for the interaction term BMI alcohol in smokers and nonsmokers after exclusion of outliers.

6 Lussier-Cacan et al Context Dependency of Alcohol Effect on Lipoproteins 829 Figure 3. Regression lines showing the association between BMI and predicted HDL-C levels (mmol/l) according to drinking status (non-drinkers and drinkers) in women with the 3/3 and 4/3 genotypes, in smokers (upper panel) and non-smokers (lower panel). The P value presented in the figure is the probability associated with the regression coefficient ( ) obtained in model D for the interaction term BMI alcohol in smokers and non-smokers after exclusion of outliers. risk of CVD. In this regard, we observed the widely documented elevating effect of alcohol on HDL-C and apoa-i levels. 3 We found that after adjusting for age and BMI, this effect was not dependent on APOE genotype when other measures of context were ignored (model B). However, further subgroup analyses provided convincing evidence for heterogeneity among APOE genotypes of the influence of the interactions between alcohol, BMI, and smoking on variation in levels of both LDL-C and HDL-C. Specifically, we found that the increase in LDL-C with increasing BMI was significantly greater in drinkers than in non-drinkers and this complex interaction was observed only in women with the 4/3 genotype (Figure 1). This apparent synergistic effect of alcohol intake and increasing BMI on LDL-C levels showed even more complexity when the influence of smoking was considered. The interaction was stronger in smokers than in non-smokers (Figure 2). In these same women with the 4/3 genotype, the decrease in HDL-C with increasing BMI was greater in drinkers compared with non-drinkers, especially in non-smokers (Figure 3). We conclude that in 4/3 women only, alcohol consumption intensifies the expected increase in LDL-C and decrease in HDL-C associated with increasing BMI. The influence of the alcohol by BMI interaction on LDL-C is greatest in smokers while the effect on HDL-C is greatest in non-smokers. The consideration of the role of age, BMI, smoking, physical activity, social economic status, energy intake, or menopausal status on the effect of alcohol has not been consistently addressed previously. Only a few studies have evaluated the influence of the apoe polymorphism on the contribution of alcohol intake to variation in measures of lipid metabolism and they differ greatly in their objectives and the analytical methods that were used. 11,12,26,27 Statistical approaches have included multiple linear regression analyses 11,26 or adjusted correlation coefficients 12 in separate, or pooled, 27 APOE subgroups. One recent study 27 found that increased levels of LDL-C in carriers of the 4 allele and decreased levels in the carriers of the 2 allele were present in both drinkers and non-drinkers in women but were observed only in drinkers in men. This gender-specific effect of APOE genotype variation remained statistically significant after adjustment for age, BMI, smoking status, and fat and energy intake. Such studies serve to further document the importance of considering the role of context in evaluating the role that genetic variation can play in predicting and understanding the distribution of CVD risk in the population at large. To explore the possibility that the gender-alcohol-smoking-genotype dependent relationships between LDL-C or HDL-C and BMI are influenced by additional measures of lifestyle, we repeated the regression analyses associated with Figures 1 to 3 and included physical activity (2 levels), family income and education level (3 categories each), and hypertension (yes or no, based on elevated diastolic blood pressure at interview or antihypertensive therapy) as concomitants in model A. The observed influence of an alcohol by BMI interaction effect on LDL-C and HDL-C variation in the 4/3 subgroups of women remained statistically significant after adjustment (not shown). This result argues that, in our study, the influence of alcohol was not a consequence of factors that are correlated with these important predictors of human health. Gender-specific effects of genetic variation on measures of lipid metabolism have been repeatedly demonstrated in studies of the APOE gene The ability of environmental indices to predict interindividual variation in lipid and other biological traits also differs between women and men. 17,32,33 Favorable changes in lipid and lipoprotein levels have been associated with moderate levels of alcohol intake in women. 34,35 The recent increase in smoking prevalence in women further emphasizes the gender-specific roles that components of lifestyle 36 may take in determining risk of CVD. Our finding that the APOE genotype specific influence of alcohol and smoking on the relationship between LDL-C and HDL-C

7 830 Arterioscler Thromb Vasc Biol. May 2002 and BMI was observed only in women serves to further reinforce the relevance of considering women and men separately when interpreting the contribution of genetic, environmental, and lifestyle variations to predicting and understanding CVD. Gender differences in the distribution of CVD risk factors, and the thoroughly documented differences in the life history of CVD between men and women, 37 document the need for separate consideration of the genders in CVD studies. Knowledge of how biological differences between genders influence health can benefit both women and men. The artificial reality created by pooling genders and the reporting of gender-adjusted statistical relationships between variation in measures of health and genetic variation has become a deterrent to progress in all aspects of medical research. 38 In summary, we have shown that the influence of alcohol and cigarette smoking on variation in measures of CVD risk are not independent and the effects of non-additivity of the influences of alcohol, smoking, and BMI on the prediction of levels of both the bad LDL-C and the good HDL-C are dependent on context defined by gender and APOE genotype. Our statistical findings are consistent with the biological reality that interactions among genetic and environmental agents play an important role in the determination of interindividual variation in the onset, progression, and severity of a common disease. Accepting this reality is especially relevant for those researchers seeking to establish the functional effects of gene variations. Indeed, the influence of variation in a gene or interindividual variation in any measure of health cannot be realistically evaluated unless the concomitant factors that define the context in which the variations occur are considered in the design, analysis, and interpretation of the study. 31,39 41 Such knowledge offers the possibility of targeting subgroups of individuals who will benefit most from therapeutic programs while minimizing the potential for unexpected negative effects. Finally, this study validates the reality that neither genes nor environments, but their interactions, are the primary causes of variation in measures of health that have a complex multifactorial etiology. Acknowledgments This study was supported by the Fonds de la Recherche en Santé du Québec (FRSQ) within the joint FRSQ-Santé Québec program. The apolipoprotein data were acquired under a grant from Health and Welfare Canada (#6606 to 4543-H) to P.W. Connelly and colleagues (Jean Davignon, Bruce Reeder, Robert Hegele, Richard Lessard, Adele Csima and Suzanne Cacan). References 1. Castelli WP. Lipids, risk factors and ischaemic heart disease. Atherosclerosis. 1996;124:S1 S9. 2. Davignon J, Cohn JS. Triglycerides: a risk factor for coronary heart disease. Atherosclerosis. 1996;124:S57 S Savolainen MJ, Kesäniemi YA. Effects of alcohol on lipoproteins in relation to coronary heart disease. Curr Opin Lipidol. 1995;6: De Oliveira e Silva ER, Foster D, Harper MM, Seidman CE, Smith JD, Breslow JL, Brinton EA. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation. 2000;102: Phillips NR, Havel RJ, Kane JP. Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides: association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine. Arteriosclerosis. 1981;1: Imamura H, Tanaka K, Hirae C, Futagami T, Yoshimura Y, Uchida K, Tanaka A, Kobata D. Relationship of cigarette smoking to blood pressure and serum lipids and lipoproteins in men. Clin Exp Pharmacol Physiol. 1996;23: Porkka KVK, Ehnholm C. Smoking, alcohol and lipoprotein metabolism. Curr Opin Lipidol. 1996;7: Whitehead TP, Robinson D, Allaway SL. The effects of cigarette smoking and alcohol consumption on blood lipids: a dose-related study on men. Ann Clin Biochem. 1996;33(Pt 2): Handa K, Tanaka H, Shindo M, Kono S, Sasaki J, Arakawa K. Relationship of cigarette smoking to blood pressure and serum lipids. Atherosclerosis. 1990;84: Davignon J. Apolipoprotein E polymorphism and atherosclerosis. In: Born GVR, Schwartz CJ, eds. New Horizons in Coronary Heart Disease. London: Current Science; 1993: Robertson FW, Cumming AM. Effects of apoprotein E polymorphism on serum lipoprotein concentration. Arteriosclerosis. 1985;5: Boer JMA, Ehnholm C, Menzel HJ, Havekes LM, Rosseneu M, O Reilly DS, Tiret L. Interactions between lifestyle-related factors and the ApoE polymorphism on plasma lipids and apolipoproteins: The EARS study. Arterioscler Thromb Vasc Biol. 1997;17: Srinivasan SR, Ehnholm C, Elkasabany A, Berenson G. Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood: The Bogalusa Heart Study. Atherosclerosis. 1999;143: Reilly SL, Ferrell RE, Kottke BA, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota, II: regression relationships with concomitants. Am J Hum Genet. 1992;51: Zerba KE, Ferrell RE, Sing CF. Genotype-environment interaction: apolipoprotein E (apoe) gene effects and age as an index of time and spatial context in the human. Genetics. 1996;143: Nelson MR, Kardia SLR, Ferrell RE, Sing CF. Influence of apolipoprotein E genotype variation on the means, variances, and correlations of plasma lipids and apolipoproteins in children. Ann Hum Genet. 1999; 63: Lussier-Cacan S, Bolduc A, Xhignesse M, Niyonsenga T, Connelly PW, Sing CF. Impact of age and body size on inter-individual variation in measures of lipid metabolism: influence of gender and apolipoprotein E genotype. Clin Genet. 2000;57: Connelly PW, MacLean DR, Horlick L, O Connor B, Petrasovits A, Little JA, Canadian Heart Health Survey Research Group. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Can Med Assoc J. 1992;146: Connelly PW, Poapst M, Davignon J, Lussier-Cacan S, Reeder BA, Lessard R, Hegele RA, Csima A. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan Canadian Heart Health Surveys Research Group. Can J Cardiol. 1999; 15: Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18: Hill JS, Pritchard PH. Improved phenotyping of apolipoprotein E: application to population frequency distribution. Clin Chem. 1990;36: Snedecor GW, Cochran WG. Statistical Methods. Ames, Iowa: Iowa State University Press; Reilly SL, Kottke BA, Sing CF. The effect of generation and gender on the joint distribution of lipid and apolipoprotein phenotypes in the population at large. J Clin Epidemiol. 1990;43: Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. The genderspecific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am J Hum Genet. 1991;49: Sokal RR, Rohlf EJ. Biometry: the Principles and Practice of Statistics in Biological Research. New York: WH Freeman Co.; Sonnenberg LM, Quatromoni PA, Gagnon DR, Cupples LA, Franz MM, Ordovas JM, Wilson PWF, Schaefer EJ, Millen BE. Diet and plasma lipids in women, 2: macronutrients and plasma triglycerides, high-density lipoprotein, and the ratio of total to high density lipoprotein cholesterol in women: The Framingham nutrition studies. J Clin Epidemiol. 1996;49: Corella D, Tucker K, Lahoz C, Coltell O, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM. Alcohol drinking determines the effect of the

8 Lussier-Cacan et al Context Dependency of Alcohol Effect on Lipoproteins 831 APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am J Clin Nutr. 2001;73: Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb. 1991; 11: Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb. 1991;11: Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, Wilson PWF. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: results from the Framingham Offspring Study. Arterioscler Thromb. 1994;14: Frikke-Schmidt R, Nordestgaard BG, Agerholm-Larsen B, Schnohr P, Tybjærg-Hansen A. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J Lipid Res. 2000;41: Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J Jr. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr. 1996;64: Lussier-Cacan S, Xhignesse M, Kessling AM, Davignon J, Sing CF. Sources of variation in plasma lipid and lipoprotein traits in a sample selected for health. Am J Epidemiol. 1999;150: Clevidence BA, Reichman ME, Judd JT, Muesing RA, Schatzkin A, Schaefer EJ, Li Z, Jenner J, Brown CC, Sunkin M, Campbell WS, Taylor PR. Effects of alcohol consumption on lipoproteins of premenopausal women: a controlled diet study. Arterioscler Thromb. 1995;15: Nanchahal K, Ashton WD, Wood DA. Alcohol consumption, metabolic cardiovascular risk factors and hypertension in women. Int J Epidemiol. 2000;29: Canadian Tobacco Use Monitoring Survey (CTUMS), 5: Youth and Young Adults. Wave Health Canada, Gov. of Canada, Ottawa Barrett-Connor E. Sex differences in coronary heart disease: why are women so superior? The 1995 Ancel Keys Lecture. Circulation. 1997; 95: Pardue ML. Studying differences between the sexes may spur improvements in medicine. The Scientist. 2001;15: Turner ST, Boerwinkle E, Sing CF. Context-dependent associations of the ACE I/D polymorphism with blood pressure. Hypertension. 1999;34: Holdrege C. In Genetics and the Manipulation of Life: the Forgotten Factor of Context. Renewal in Science. Hudson, NY: Lindisfarne Press; Lewontin RC. The Triple Helix: Gene, Organism, and Environment. Cambridge, Mass: Harvard University Press; Zerba KE, Sing CF. The role of genome type environment interaction and time in understanding the impact of genetic polymorphisms on lipid metabolism. Curr Opin Lipidol. 1993;4: Sing CF, Haviland MB, Reilly SL. Genetic architecture of common multifactorial diseases. Ciba Found Symp 1996;197:

Hyperlipidemia is a major risk factor for cardiovascular

Hyperlipidemia is a major risk factor for cardiovascular Impact of Alcohol Intake on Measures of Lipid Metabolism Depends on Context Defined by Gender, Body Mass Index, Cigarette Smoking, and Apolipoprotein E Genotype Suzanne Lussier-Cacan, Aline Bolduc, Marianne

More information

Katsuyuki Nakajima, PhD. Member of JCCLS International Committee

Katsuyuki Nakajima, PhD. Member of JCCLS International Committee Katsuyuki Nakajima, PhD Member of JCCLS International Committee Visiting Professor and Scientist Tufts University, Boston, MA & Framingham Offspring Study, Framingham, MA August 20 th, 2011, Tokyo Framingham

More information

Study of relationship of serum Lipid Profile and etiological factors of Ischaemic Heart Diseases

Study of relationship of serum Lipid Profile and etiological factors of Ischaemic Heart Diseases Original article: Study of relationship of serum Lipid Profile and etiological factors of Ischaemic Heart Diseases Dr Abhijit Nikam, Dr Sonu Yadav, Dr Vivek Chiddarwar, Dr A L Kakrani Dept of Medicine,

More information

Lipoprotein (a): Is it important for Friedewald formula?

Lipoprotein (a): Is it important for Friedewald formula? ORIGINAL RESEARCH ALBANIAN MEDICAL JOURNAL Lipoprotein (a): Is it important for Friedewald formula? Murat Can 1, Berrak Guven 1 1 Bulent Ecevit University, Faculty of Medicine, Department of Biochemistry

More information

Influence of apolipoprotein E genotype variation on the means, variances, and correlations of plasma lipids and apolipoproteins in children

Influence of apolipoprotein E genotype variation on the means, variances, and correlations of plasma lipids and apolipoproteins in children Ann. Hum. Genet. (1999), 63, 311 328 Printed in Great Britain 311 Influence of apolipoprotein E genotype variation on the means, variances, and correlations of plasma lipids and apolipoproteins in children

More information

Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease

Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease Original article: Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease Dr Sonu Yadav, Dr Abhijit Nikam, Dr Vivek Chiddarwar, Dr A L Kakrani Department of Medicine,

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32. Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043

More information

TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia

TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia (2005) 13, 877 882 & 2005 Nature Publishing Group All rights reserved 1018-4813/05 $30.00 www.nature.com/ejhg ARTICLE TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL A Meta-analysis of LDL-C, non-hdl-c, and apob as markers of cardiovascular risk. Slide # Contents 2 Table A1. List of candidate reports 8 Table A2. List of covariates/model adjustments

More information

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,

More information

Looking Toward State Health Assessment.

Looking Toward State Health Assessment. CONNECTICUT DEPARTMENT OF PUBLIC HEALTH Policy, Planning and Analysis. Looking Toward 2000 - State Health Assessment. Table of Contents Glossary Maps Appendices Publications Public Health Code PP&A Main

More information

Introduction ORIGINAL INVESTIGATION. Jari H. Stengård Kenneth M. Weiss Charles F. Sing

Introduction ORIGINAL INVESTIGATION. Jari H. Stengård Kenneth M. Weiss Charles F. Sing Hum Genet (1998) 103 : 234 241 Springer-Verlag 1998 ORIGINAL INVESTIGATION Jari H. Stengård Kenneth M. Weiss Charles F. Sing An ecological study of association between coronary heart disease mortality

More information

The Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)

The Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) The Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Recruitment The majority of participants in the GOLDN Study were re-recruited from threegenerational pedigrees from two National Heart, Lung

More information

Prevention of Cardiovasular Diseases

Prevention of Cardiovasular Diseases Role and Significance of In-Vitro-Diagnostics in the Healthcare Systems of the Future Prevention of Cardiovasular Diseases Michael Walter Charité University Medicine, Berlin & Unfallkrankenhaus Berlin

More information

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:

More information

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk? There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk? Michael Davidson M.D. FACC, Diplomate of the American Board of Lipidology Professor,

More information

Pathophysiology of Lipid Disorders

Pathophysiology of Lipid Disorders Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society

More information

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original

More information

Management of dyslipidaemia in HIV infected children: rationale for treatment algorithm

Management of dyslipidaemia in HIV infected children: rationale for treatment algorithm Management of dyslipidaemia in HIV infected children: rationale for treatment algorithm Authors: Julie Lanigan, Lisa Cooke and Clare Stradling Date of Preparation: September 2010 Date reviewed: October

More information

Friedewald formula. ATP Adult Treatment Panel III L D L Friedewald formula L D L = T- C H O - H D L - T G / 5. Friedewald formula. Friedewald formula

Friedewald formula. ATP Adult Treatment Panel III L D L Friedewald formula L D L = T- C H O - H D L - T G / 5. Friedewald formula. Friedewald formula Friedewald formula 1 1 1,2 ATP Adult Treatment Panel III L D L Friedewald formula L D L = T- C H O - H D L - T G / 5 Friedewald formula Friedewald formula 2003 99 Friedewald formula Colorimetric method

More information

Page 1. Disclosures. Background. No disclosures

Page 1. Disclosures. Background. No disclosures Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen

More information

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien

More information

1. Which one of the following patients does not need to be screened for hyperlipidemia:

1. Which one of the following patients does not need to be screened for hyperlipidemia: Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:

More information

The importance of both low-density lipoprotein

The importance of both low-density lipoprotein Improving the Prediction of Cardiovascular Risk: Interaction Between LDL and HDL Cholesterol Steven A. Grover, 1,2,3,4 Marc Dorais, 1,3 and Louis Coupal 1,3 Background. The ratio of total cholesterol to

More information

Medical - Clinical Research & Reviews

Medical - Clinical Research & Reviews Research Article Research Article Medical - Clinical Research & Reviews ISSN 2575-6087 Association of BMI and Waist to Hip Ratio with the Ratio of LDL to HDL and Total Cholesterol to HDL in Urban Adolescents

More information

行政院國家科學委員會補助專題研究計畫成果報告

行政院國家科學委員會補助專題研究計畫成果報告 NSC892314B002270 898 1 907 31 9010 23 1 Molecular Study of Type III Hyperlipoproteinemia in Taiwan β β ε E Abstract β Type III hyperlipoproteinemia (type III HLP; familial dysbetalipoproteinemia ) is a

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Section: Genetic Testing Last Reviewed Date: December Policy No: 05 Effective Date: March 1, 2014

Section: Genetic Testing Last Reviewed Date: December Policy No: 05 Effective Date: March 1, 2014 Medical Policy Manual Topic: Apolipoprotein E for Risk Assessment and Management of Cardiovascular Disease Date of Origin: January 2013 Section: Genetic Testing Last Reviewed Date: December 2013 Policy

More information

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of

More information

A comparison of statistical methods for adjusting the treatment effects in genetic association studies of quantitative traits

A comparison of statistical methods for adjusting the treatment effects in genetic association studies of quantitative traits 34 1 Journal of the Korean Society of Health Information and Health Statistics Volume 34, Number 1, 2009, pp. 53 62 53 한경화 1), 임길섭 2), 박성하 3), 장양수 4), 송기준 2) 1), 2), 3), 4) A comparison of statistical

More information

The Framingham Coronary Heart Disease Risk Score

The Framingham Coronary Heart Disease Risk Score Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although

More information

Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol

Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol Erdembileg Anuurad,* Jill Rubin, Guijing Lu,* Thomas A. Pearson, Steve

More information

Trends in adult obesity

Trends in adult obesity 53 by Margot Shields and Michael Tjepkema Keywords: body mass index, body weight, income, smoking In recent years, the percentage of Canadian adults with excess weight has increased considerably, part

More information

Factors Associated with Lipoprotein Cholesterol Levels

Factors Associated with Lipoprotein Cholesterol Levels Factors Associated with Lipoprotein Cholesterol Levels The Framingham Study Peter W. F. Wilson, Robert J. Garrison, Robert D. Abbott, and William P. Castelli Lipoprotein cholesterol determinations in 6328

More information

Non-fasting Lipid Profile Getting to the Heart of the Matter! Medimail Dec 2017

Non-fasting Lipid Profile Getting to the Heart of the Matter! Medimail Dec 2017 Non-fasting Lipid Profile Getting to the Heart of the Matter! Medimail Dec 2017 Historical Basis for Fasting Lipids The initial classifications of hyperlipidemia proposed in 1967 were genetic and required

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Nature Genetics: doi: /ng.3561

Nature Genetics: doi: /ng.3561 Supplementary Figure 1 Pedigrees of families with APOB p.gln725* mutation and APOB p.gly1829glufs8 mutation (a,b) Pedigrees of families with APOB p.gln725* mutation. (c) Pedigree of family with APOB p.gly1829glufs8

More information

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein

More information

Metabolic Syndrome: Why Should We Look For It?

Metabolic Syndrome: Why Should We Look For It? 021-CardioCase 29/05/06 15:04 Page 21 Metabolic Syndrome: Why Should We Look For It? Dafna Rippel, MD, MHA and Andrew Ignaszewski, MD, FRCPC CardioCase presentation Andy s fatigue Andy, 47, comes to you

More information

Evaluation of Calculated Low-Density Lipoprotein Against a Direct Assay

Evaluation of Calculated Low-Density Lipoprotein Against a Direct Assay Evaluation of Calculated Low-Density Lipoprotein Against a Direct Assay Navapun Charuruks MD*, Anna Milintagas BSc** * Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University **

More information

Disclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017

Disclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017 Disclosures MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES Grants: NIH, Quest Diagnostics Consultant: Quest Diagnostics Merck Global Atherosclerosis Advisory Board Ronald M. Krauss, Children s Hospital

More information

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised

More information

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures Lipoprotein (a): Should We Measure? Should We Treat? Joseph P. McConnell, Ph.D. DABCC Health Diagnostic Laboratory Inc. Baptist Health South Florida Eleventh Annual Cardiovascular Disease Prevention International

More information

CARDIOVASCULAR RISK FACTORS IN WHITE COLLAR WORKERS UNDER SHIFT WORK. K. Vangelova. National Center of Public Health and Analyses Sofia, Bulgaria

CARDIOVASCULAR RISK FACTORS IN WHITE COLLAR WORKERS UNDER SHIFT WORK. K. Vangelova. National Center of Public Health and Analyses Sofia, Bulgaria 10.1515/AMB-2017-0011 ORIGINAL ARTICLES CARDIOVASCULAR RISK FACTORS IN WHITE COLLAR WORKERS UNDER SHIFT WORK K. Vangelova National Center of Public Health and Analyses Sofia, Bulgaria Abstract. Shift work

More information

Kansas Nutrition Project

Kansas Nutrition Project Kansas Nutrition Project M. J. Mosher Dept. of Epidemiology University of North Carolina Presented to 3 rd Nordic Epidemiology Conf Koupio, Finland June 2004 Funding State of Kansas Attorney General s

More information

Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins

Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins Muller H, Jordal O, et al. (998) Replacement of partially hydrogenated soybean

More information

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries Lipid Disorders in Diabetes (Diabetic Dyslipidemia) Khosrow Adeli PhD, FCACB, DABCC Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University it of Toronto Diabetes A Global

More information

Relation between Abdominal Fat and Serum Cholesterol, Triglycerides, and Lipoprotein Concentrations in Chicken Breeds

Relation between Abdominal Fat and Serum Cholesterol, Triglycerides, and Lipoprotein Concentrations in Chicken Breeds Turk. J. Vet. Anim. Sci. 2007; 3(6): 375-379 TÜB TAK Research Article Relation between Abdominal Fat and Serum Cholesterol, Triglycerides, and Lipoprotein Concentrations in Chicken Breeds Hassan H. MUSA,2,

More information

Zuhier Awan, MD, PhD, FRCPC

Zuhier Awan, MD, PhD, FRCPC Metabolism, Atherogenic Properties and Agents to Reduce Triglyceride-Rich Lipoproteins (TRL) The Fifth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 8-11, 2019 Zuhier

More information

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416). Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52

More information

Lipids, Lipoproteins and Cardiovascular Risk: Getting the Most out of New and Old Biomarkers. New and Old Biomarkers. Disclosures

Lipids, Lipoproteins and Cardiovascular Risk: Getting the Most out of New and Old Biomarkers. New and Old Biomarkers. Disclosures Lipids, Lipoproteins and Cardiovascular Risk: Getting the Most out of New and Old Biomarkers William Cromwell, MD, FAHA, FNLA Diplomate, American Board of Clinical Lipidology Chief Lipoprotein and Metabolic

More information

New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines

New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines Clin. Cardiol. Vol. 26 (Suppl. III), III-19 III-24 (2003) New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines H. BRYAN BREWER, JR, M.D. Molecular

More information

HIV and Co-morbidities November 18, 2013, 3:10 pm Abstract Number 141

HIV and Co-morbidities November 18, 2013, 3:10 pm Abstract Number 141 Low omega-3 index in erythrocytes is a risk factor for progression of atherosclerosis in people living with HIV Bianca M Arendt, M Smieja, IE Salit, DWL Ma, F Smaill, D Elston, E Lonn, Johane P Allard

More information

LIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV

LIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 4 (53) No. 2-2011 LIPIDS AND CHOLESTEROL - RISK FACTORS TO A POLICE UNIT FROM BRASOV C. DOBRESCU 1 I. MOLEAVIN 1 Abstract:

More information

ATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS

ATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS LABORATORY AND RISK FACTORS OF ATHEROSCLEROSIS S R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty RISK FACTORS FOR CHD Clinical Risk Factors Laboratory Risk Factors MAJOR CLINICAL RISK

More information

Despite substantial declines over the past decade,

Despite substantial declines over the past decade, 19 The journey to quitting smoking Margot Shields Abstract Objectives This article outlines smoking trends over the past 10 years among the population aged 18 or older. Factors associated with smoking

More information

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION 2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL

More information

Effect of Smoking, Alcohol and Exercise on the Prevalence of Metabolic Syndrome in a Cohort of Royal Jordanian Air Pilots

Effect of Smoking, Alcohol and Exercise on the Prevalence of Metabolic Syndrome in a Cohort of Royal Jordanian Air Pilots Effect of Smoking, Alcohol and Exercise on the Prevalence of Metabolic Syndrome in a Cohort of Royal Jordanian Air Pilots Nawaf Khazale MD*, Fares Haddad MD** ABSTRACT Objectives: To assess whether smoking,

More information

Measurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Original Policy Date

Measurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Original Policy Date MP 2.04.22 Measurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with

More information

Longitudinal Trajectories of Cholesterol from Midlife through Late Life according to Apolipoprotein E Allele Status

Longitudinal Trajectories of Cholesterol from Midlife through Late Life according to Apolipoprotein E Allele Status Int. J. Environ. Res. Public Health 2014, 11, 10663-10693; doi:10.3390/ijerph111010663 OPEN ACCESS Article International Journal of Environmental Research and Public Health ISSN 1660-4601 www.mdpi.com/journal/ijerph

More information

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools. UW MEDICINE UW MEDICINE UCSF ASIAN TITLE HEALTH OR EVENT SYMPOSIUM 2017 DISCLOSURES Consultant: RubiconMD ESTIMATING CV RISK IN ASIAN AMERICANS AND PREVENTION OF CVD Research: Amgen, NHLBI EUGENE YANG,

More information

Apolipoprotein E Polymorphism and Heterozygous Familial Hypercholesterolemia. Sex-Specific Effects

Apolipoprotein E Polymorphism and Heterozygous Familial Hypercholesterolemia. Sex-Specific Effects 1553 Apolipoprotein E Polymorphism and Heterozygous Familial Hypercholesterolemia Sex-Specific Effects Jean Ferrieres, Charles F. Sing, Madeleine Roy, Jean Davignon, Suzanne Lussier-Cacan Abstract The

More information

Comparison of Lipoprotein (a) and Apolipoproteins in Children with and without Familial History of Premature Coronary Artery Disease

Comparison of Lipoprotein (a) and Apolipoproteins in Children with and without Familial History of Premature Coronary Artery Disease Short Comunication Iran J Pediatr Jun 2008; Vol 18 ( No 2), Pp:159-162 Comparison of Lipoprotein (a) and Apolipoproteins in Children with and without Familial History of Premature Coronary Artery Disease

More information

Familial combined hyperlipidemia (FCH) was first described

Familial combined hyperlipidemia (FCH) was first described Clinical Investigation and Reports Nomogram to Diagnose Familial Combined Hyperlipidemia on the Basis of Results of a 5-Year Follow-Up Study Mario J. Veerkamp, MD; Jacqueline de Graaf, MD, PhD; Jan C.M.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Magnussen CG, Thomson R, Cleland VJ, Ukoumunne OC, Dwyer T, Venn A. Factors affecting the stability of blood lipid and lipoprotein levels from youth to adulthood: evidence

More information

Evaluation of Anthropometric Indices of Patients with Left Ventricle Dysfunction Fallowing First Acute Anterior Myocardial Infarction

Evaluation of Anthropometric Indices of Patients with Left Ventricle Dysfunction Fallowing First Acute Anterior Myocardial Infarction Journal of Cardiovascular and Thoracic Research, 2012, 4(1), 11-15 doi: 10.5681/jcvtr.2012.003 http://jcvtr.tbzmed.ac.ir Evaluation of Anthropometric Indices of Patients with Left Ventricle Dysfunction

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations

The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations Atherosclerosis 179 (2005) 161 167 The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations Leena E. Viiri a,, Antti Loimaala b,c,

More information

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies Mohsen Mazidi 1, Niki Katsiki 2, Dimitri P. Mikhailidis 3, Maciej Banach

More information

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese

Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,

More information

. Non HDL-c : Downloaded from ijdld.tums.ac.ir at 18:05 IRDT on Friday March 22nd Non HDL LDL. . LDL Non HDL-c

. Non HDL-c : Downloaded from ijdld.tums.ac.ir at 18:05 IRDT on Friday March 22nd Non HDL LDL. . LDL Non HDL-c 208-23 (2 ) 0 389 -. Non HDL * Downloaded from ijdld.tums.ac.ir at 8:05 IRDT on Friday March 22nd 209 Non HDL : LDL.. 5 3277 :.. odds ratio Chi-Square %3/9 Non HDL-C %2 LDL-C. %3 : Non-HDL-C LDL-C. (CI

More information

etable 3.1: DIABETES Name Objective/Purpose

etable 3.1: DIABETES Name Objective/Purpose Appendix 3: Updating CVD risks Cardiovascular disease risks were updated yearly through prediction algorithms that were generated using the longitudinal National Population Health Survey, the Canadian

More information

290 Biomed Environ Sci, 2016; 29(4):

290 Biomed Environ Sci, 2016; 29(4): 290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur

More information

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) I. TEST YOUR KNOWLEDGE OF CHOLESTEROL Choose the correct answer. 1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver) 2. Only

More information

Dietary Patterns and the Metabolic Syndrome in Obese and Non-obese Framingham Women

Dietary Patterns and the Metabolic Syndrome in Obese and Non-obese Framingham Women Risk Factors and Chronic Disease Dietary Patterns and the Metabolic Syndrome in Obese and Non-obese Framingham Women Lillian Sonnenberg,* Michael Pencina, Ruth Kimokoti, Paula Quatromoni, Byung-Ho Nam,

More information

Effects of whole grain intake on weight changes, diabetes, and cardiovascular Disease

Effects of whole grain intake on weight changes, diabetes, and cardiovascular Disease Effects of whole grain intake on weight changes, diabetes, and cardiovascular Disease Simin Liu, MD, ScD Professor of Epidemiology and Medicine Director, Center for Global Cardiometabolic Health Brown

More information

Clinical Investigation and Reports

Clinical Investigation and Reports Clinical Investigation and Reports The Apolipoprotein 4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction A Substudy of the Scandinavian Simvastatin

More information

Genetic testing in cardiovascular disease Atul K. Sachdev, MD

Genetic testing in cardiovascular disease Atul K. Sachdev, MD Genetic testing in cardiovascular disease Atul K. Sachdev, MD New Horizon Healthcare 1 Disclosures Speaker Quest/Cleveland HeartLab 9p21 The heart attack gene 9p21 is a region of the genome on the short

More information

Exercise Training-Induced Blood Pressure and Plasma Lipid Improvements in Hypertensives May Be Genotype Dependent

Exercise Training-Induced Blood Pressure and Plasma Lipid Improvements in Hypertensives May Be Genotype Dependent Exercise Training-Induced Blood Pressure and Plasma Lipid Improvements in Hypertensives May Be Genotype Dependent James M. Hagberg, Robert E. Ferrell, Donald R. Dengel, Kenneth R. Wilund Abstract Exercise

More information

Cardiorespiratory Fitness is Strongly Related to the Metabolic Syndrome in Adolescents. Queen s University Kingston, Ontario, Canada

Cardiorespiratory Fitness is Strongly Related to the Metabolic Syndrome in Adolescents. Queen s University Kingston, Ontario, Canada Diabetes Care In Press, published online May 29, 2007 Cardiorespiratory Fitness is Strongly Related to the Metabolic Syndrome in Adolescents Received for publication 16 April 2007 and accepted in revised

More information

What Else Do You Need to Know? Presenter Disclosure Information. Case 1: Cardiovascular Risk Assessment in a 53-Year-Old Man. Learning Objectives

What Else Do You Need to Know? Presenter Disclosure Information. Case 1: Cardiovascular Risk Assessment in a 53-Year-Old Man. Learning Objectives 9: 1:am Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis SPEAKER Matthew Sorrentino, MD, FACC Presenter Disclosure Information The following relationships exist

More information

MOLINA HEALTHCARE OF CALIFORNIA

MOLINA HEALTHCARE OF CALIFORNIA MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel

More information

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular

More information

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, PHYSICAL HEALTH, AND LIFESTYLE IN OLDER ADULTS

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, PHYSICAL HEALTH, AND LIFESTYLE IN OLDER ADULTS CHAPTER 5 ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, PHYSICAL HEALTH, AND LIFESTYLE IN OLDER ADULTS J. AM. GERIATR. SOC. 2013;61(6):882 887 DOI: 10.1111/JGS.12261 61 ATTENTION-DEFICIT/HYPERACTIVITY DISORDER,

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made

More information

Familial hypercholesterolaemia in children and adolescents

Familial hypercholesterolaemia in children and adolescents Familial hypercholesterolaemia in children and adolescents Rationale and recommendations for early identification and treatment European Atherosclerosis Society Consensus Panel Slide deck adapted from:

More information

Recently reported clinical trials have provided strong

Recently reported clinical trials have provided strong Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions The Atherosclerosis Risk in Communities (ARIC)

More information

CVD risk calculation

CVD risk calculation CVD risk calculation Cardiovascular disease (CVD) is the most common cause of death in Alberta, accounting for nearly one third (31%) of the overall deaths (1). The majority (90%) of the CVD cases are

More information

The Second Report of the Expert Panel on Detection,

The Second Report of the Expert Panel on Detection, Blood Cholesterol Screening Influence of State on Cholesterol Results and Management Decisions Steven R. Craig, MD, Rupal V. Amin, MD, Daniel W. Russell, PhD, Norman F. Paradise, PhD OBJECTIVE: To compare

More information

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health The Mediterranean Diet: The Optimal Diet for Cardiovascular Health Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health Cardiovascular Disease Prevention International

More information

Central role of apociii

Central role of apociii University of Copenhagen & Copenhagen University Hospital Central role of apociii Anne Tybjærg-Hansen MD DMSc Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen,

More information

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis

More information

Review of guidelines for management of dyslipidemia in diabetic patients

Review of guidelines for management of dyslipidemia in diabetic patients 2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University

More information

5/28/2010. Pre Test Question

5/28/2010. Pre Test Question Myth of Metabolic Syndrome? C. W. Spellman, DO, PhD Professor and Associate Dean Research Dir. Center Diabetes and Metabolic Disorders Department Internal Medicine, Div. Endocrinology Texas Tech University

More information

Overview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures

Overview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures The Mediterranean Diet: The Optimal Diet for Cardiovascular Health No conflicts of interest or disclosures Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health

More information